NIOX Group Plc (AIM: NIOX)
London
· Delayed Price · Currency is GBP · Price in GBX
63.00
-0.60 (-0.94%)
Jan 22, 2025, 9:39 AM GMT+1
NIOX Group Revenue
NIOX Group had revenue of 21.00M GBP in the half year ending June 30, 2024, with 35.48% growth. This brings the company's revenue in the last twelve months to 39.00M, up 12.72% year-over-year. In the year 2023, NIOX Group had annual revenue of 36.80M with 17.57% growth.
Revenue (ttm)
39.00M
Revenue Growth
+12.72%
P/S Ratio
6.88
Revenue / Employee
423.91K
Employees
92
Market Cap
253.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 36.80M | 5.50M | 17.57% |
Dec 31, 2022 | 31.30M | 3.40M | 12.19% |
Dec 31, 2021 | 27.90M | 4.00M | 16.74% |
Dec 31, 2020 | 23.90M | -10.70M | -30.92% |
Dec 31, 2019 | 34.60M | -13.70M | -28.36% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |